CDK9 As a New Therapeutic Vulnerability for Ibrutinib Resistance Mantle Cell Lymphoma (MCL)

被引：0
|
作者：
Wang, Michelle
Zhao, Xiaohong
Jiang, Huijuan
Yan, Joy Catherine
Sotomayor, Eduardo
Shain, Kenneth H.
Shah, Bijal
Tao, Jianguo
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
    Lemke, J.
    von Karstedt, S.
    Abd El Hay, M.
    Conti, A.
    Arce, F.
    Montinaro, A.
    Papenfuss, K.
    El-Bahrawy, M. A.
    Walczak, H.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (03): : 491 - 502
  • [32] Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects
    Hershkovitz-Rokah, Oshrat
    Pulver, Dana
    Lenz, Georg
    Shpilberg, Ofer
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 306 - 319
  • [33] Pirtobrutinib: a promising therapy for overcoming the resistance of ibrutinib in mantle cell lymphoma
    Fatima, Sania Kaneez
    Khan, Sara
    Mughal, Zaib Un Nisa
    Rangwala, Hussain Sohail
    Rangwala, Burhanuddin Sohail
    Siddiq, Mohammad Arham
    Ali, Mirha
    Farah, Asma Ahmed
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (06): : 3189 - 3191
  • [34] Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma
    Liu, Yang
    Bell, Taylor
    Zhang, Hui
    Sun, Yuting
    Li, Carrie J.
    Feng, Ningping
    Huang, Shengjian
    Guo, Hui
    Wang, Jack
    Ahmed, Makhdum
    Zhang, Victoria
    Lam, Laura T.
    Nomie, Krystle
    Zhang, Liang
    Di Francesco, Maria E.
    Marszalek, Joe
    Wang, Michael
    BLOOD, 2016, 128 (22)
  • [35] Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
    Zhao, Xiaohong
    Lwin, Tint
    Silva, Ariosto
    Shah, Bijal
    Tao, Jiangchuan
    Fang, Bin
    Zhang, Liang
    Fu, Kai
    Bi, Chengfeng
    Li, Jiannong
    Jiang, Huijuan
    Meads, Mark B.
    Jacobson, Timothy
    Silva, Maria
    Distler, Allison
    Darville, Lancia
    Zhang, Ling
    Han, Ying
    Rebatchouk, Dmitri
    Di Liberto, Maurizio
    Moscinski, Lynn C.
    Koomen, John M.
    Dalton, William S.
    Shain, Kenneth H.
    Wang, Michael
    Sotomayor, Eduardo
    Tao, Jianguo
    NATURE COMMUNICATIONS, 2017, 8
  • [36] Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
    Xiaohong Zhao
    Tint Lwin
    Ariosto Silva
    Bijal Shah
    Jiangchuan Tao
    Bin Fang
    Liang Zhang
    Kai Fu
    Chengfeng Bi
    Jiannong Li
    Huijuan Jiang
    Mark B. Meads
    Timothy Jacobson
    Maria Silva
    Allison Distler
    Lancia Darville
    Ling Zhang
    Ying Han
    Dmitri Rebatchouk
    Maurizio Di Liberto
    Lynn C. Moscinski
    John M. Koomen
    William S. Dalton
    Kenneth H. Shain
    Michael Wang
    Eduardo Sotomayor
    Jianguo Tao
    Nature Communications, 8
  • [37] CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
    Elana Thieme
    Nur Bruss
    Duanchen Sun
    Edward C. Dominguez
    Daniel Coleman
    Tingting Liu
    Carly Roleder
    Melissa Martinez
    Krystine Garcia-Mansfield
    Brian Ball
    Patrick Pirrotte
    Lili Wang
    Zheng Xia
    Alexey V. Danilov
    Molecular Cancer, 22
  • [38] CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
    Thieme, Elana
    Bruss, Nur
    Sun, Duanchen
    Dominguez, Edward C.
    Coleman, Daniel
    Liu, Tingting
    Roleder, Carly
    Martinez, Melissa
    Garcia-Mansfield, Krystine
    Ball, Brian
    Pirrotte, Patrick
    Wang, Lili
    Xia, Zheng
    Danilov, Alexey V.
    MOLECULAR CANCER, 2023, 22 (01)
  • [39] Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
    Hellvard, Annelie
    Zeitlmann, Lutz
    Heiser, Ulrich
    Kehlen, Astrid
    Niestroj, Andre
    Demuth, Hans-Ulrich
    Koziel, Joanna
    Delaleu, Nicolas
    Potempa, Jan
    Mydel, Piotr
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
    Annelie Hellvard
    Lutz Zeitlmann
    Ulrich Heiser
    Astrid Kehlen
    André Niestroj
    Hans-Ulrich Demuth
    Joanna Koziel
    Nicolas Delaleu
    Piotr Jan Potempa
    Scientific Reports, 6
12345